Medicines and IP: Balancing Innovation and Access
Judiciary: House Committee · June 4, 2026
A House Judiciary subcommittee hearing examined patent 'thickets,' the Ethic Act and a separate skinny-label bill as lawmakers and witnesses debated how to balance incentives for pharmaceutical innovation with faster access to generics and biosimilars; a Supreme Court decision on skinny labels was issued the same morning and shaped the discussion.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.